Hims & Hers Health is trading at €26.48 (+10.79%) today, driven by continued investor interest in the GLP-1 weight-loss market. - This surge extends a rebound from last week's selloff, which was triggered by an FTC lawsuit concerning marketing and subscription practices. - The company, a major player in the rapidly expanding GLP-1 telehealth sector, is seeing renewed buying interest.